Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan.

导出 OA

翻译打印收藏纠错

作者： Otília,Menyhárt ^[1] ; János Tibor,Fekete ^[2] ; Balázs,Győrffy ^[3]

作者单位： 2nd Department of Pediatrics, Semmelweis University, Tűzoltó u. 7-9, H-1094 Budapest, Hungary. menyhart.Otilia@med.semmelweis-univ.hu. ^[1] MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Hungarian Academy of Sciences, Magyar tudósok körútja 2., H-1117 Budapest, Hungary. menyhart.Otilia@med.semmelweis-univ.hu. ^[2] 2nd Department of Pediatrics, Semmelweis University, Tűzoltó u. 7-9, H-1094 Budapest, Hungary. jfeketet@hotmail.com. ^[3] MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Hungarian Academy of Sciences, Magyar tudósok körútja 2., H-1117 Budapest, Hungary. jfeketet@hotmail.com. ^[4] 2nd Department of Pediatrics, Semmelweis University, Tűzoltó u. 7-9, H-1094 Budapest, Hungary. gyorffy.balazs@ttk.mta.hu. ^[5] MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Hungarian Academy of Sciences, Magyar tudósok körútja 2., H-1117 Budapest, Hungary. gyorffy.balazs@ttk.mta.hu. ^[6]

关键词 biomarker gene arrays gene expression ovarian carcinoma resistance survival tumor microenvironment